Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Polycystic Ovary Syndrome × saxagliptin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 21 Letrozole 10 Clomiphene 6 dapagliflozin 4 Contraceptives, Oral 4 Chorionic Gonadotropin 4 cetrorelix 3 Liraglutide 3 Inositol 3 follitropin beta 2 follitropin alfa 2 drospirenone and ethinyl estradiol combination 2 Musculoskeletal Manipulations 2 Glycoprotein Hormones, alpha Subunit 2 DLBS3233 2 Cholecalciferol 2 semaglutide 1 saxagliptin 1 lime 1 follicle stimulating hormone, human, with HCG C-terminal peptide 1 drospirenone 1 cinnulin PF 1 Urofollitropin 1 Triptorelin Pamoate 1 Treatment Expectations 1 Thioctic Acid 1 Tablets 1 Sugars 1 Sperm Injections, Intracytoplasmic 1 Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02022007 2017-06-28

BMS-AZPCOS

Woman's

Phase 3 Completed

38 enrolled 17 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡